Battle brewing over mercury in vaccines

The coalition wants to see the use of mercury phased out of drug and vaccine manufacturing.

The announcement coincided with a Geneva meeting of a WHO committee to discuss international moves to replace preservative-containing multidose vials with preservative-free single-use vaccines.

The meeting heard that banning thimerosal would cost developing nations millions of dollars and there was no real research and development pipeline on alternative preservatives.